Financhill
Back

Carlisle Cos., Inc. Vs. Structure Therapeutics, Inc. Industry Stock Comparison

Sell
50

CSL
Carlisle Cos., Inc.

Last Price:
$332.67
Seasonality Move:
5.3%
Buy
67

GPCR
Structure Therapeutics, Inc.

Last Price:
$68.85
Seasonality Move:
-31.39%
Sell
50
Carlisle Cos., Inc. (CSL) is a Sell

Is Carlisle Cos., Inc. a Buy, Sell or Hold?

  • The current Carlisle Cos., Inc. [CSL] share price is $319.33. The Score for CSL is 50, which is 0% below its historic median score of 50, and infers higher risk than normal.
  • CSL is currently trading in the 40-50% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a lower than normal reading, suggesting risk levels may be somewhat higher than normal and additional caution is warranted.
Buy
67
Structure Therapeutics, Inc. (GPCR) is a Buy

Is Structure Therapeutics, Inc. a Buy, Sell or Hold?

  • The current Structure Therapeutics, Inc. [GPCR] share price is $66.74. The Score for GPCR is 67, which is 34% above its historic median score of 50, and infers lower risk than normal.
  • GPCR is currently trading in the 60-70% percentile range relative to its historical Stock Score levels.
  • This Score is currently showing a higher than normal reading, suggesting risk levels may be somewhat lower than normal.

CSL Stock Price Chart

What is Carlisle Cos., Inc.'s stock price today?

  • The Carlisle Cos., Inc. share price today is $319.33
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and CSL is experiencing buying pressure, which is a positive indicator for future bullish movement.

GPCR Stock Price Chart

What is Structure Therapeutics, Inc.'s stock price today?

  • The Structure Therapeutics, Inc. share price today is $66.74
    Based on the share price being above its 5, 20 & 50 day exponential moving averages, the current trend is considered strongly bullish and GPCR is experiencing slight buying pressure.

CSL Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): -0.48 Sell
Relative Strength Index (14 RSI): 50.23 Buy
Chaikin Money Flow: -245199 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

GPCR Technical Analysis

Chart Indicators Level Buy or Sell
MACD (12, 26): 5.4 Buy
Relative Strength Index (14 RSI): 80.52 Buy
Chaikin Money Flow: -2951117 -
Bollinger Bands Level Buy or Sell
Bollinger Bands (25): ( - ) Buy
Bollinger Bands (100): ( - ) Buy

CSL Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 320.67 Sell
20-day SMA: 313.77 Buy
50-day SMA: 322.5 Sell
200-day SMA: 358.39 Sell
8-day EMA: 319.64 Sell
20-day EMA: 318.06 Buy
50-day EMA: 326.06 Sell
200-day EMA: 355.91 Sell

GPCR Moving Averages

Moving Averages Level Buy or Sell
8-day SMA: 42.28 Buy
20-day SMA: 38.08 Buy
50-day SMA: 32.93 Buy
200-day SMA: 23.94 Buy
8-day EMA: 47.33 Buy
20-day EMA: 39.93 Buy
50-day EMA: 33.93 Buy
200-day EMA: 27.69 Buy

Carlisle Cos., Inc. Earnings Growth & CSL Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.89 per share, a decrease next quarter of $0.00 per share, a decrease this year of $1.06 per share, and an increase next year of $1.68 per share.

Structure Therapeutics, Inc. Earnings Growth & GPCR Earnings Dates

  • Analysts estimate an earnings decrease this quarter of $0.00 per share, a decrease next quarter of $0.00 per share, a decrease this year of $0.50 per share, and a decrease next year of $0.14 per share.

Carlisle Cos., Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):

Structure Therapeutics, Inc. Technical Analysis

Technical Analysis: Buy or Sell?
8-day SMA:
20-day SMA:
50-day SMA:
200-day SMA:
8-day EMA:
20-day EMA:
50-day EMA:
200-day EMA:
MACD (12, 26):
Relative Strength Index (14 RSI):
Bollinger Bands (25):
Bollinger Bands (100):